Список литературы и клинических рекомендаций, использованных при подготовке

1. Abraham S., Rivero H.G., Erlikh I.V. et al. Surgical and Nonsurgical Management of Gallstones // www.aafp.worwg/waf.pa.

2. Al-Toma A., Volta U., Auricchio R. et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders // United Eur. Gastroenterol. J. 2019. Vol. 7. N. 5. Р. 583–613. DOI: 10.1177/2050640619844125.

3. Аmerican Association for the study of Liver Diseasec. https://www.aasld.org/publications/practice-guidelines.

4. Andrén-Sandberg Å. Diagnosis and Management of Gallbladder Polyps // North Am. J. Med. Sci. 2012. Vol. 4. P. 203–211.

5. Arasaradnam R.P., Brown S., Forbes A. et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology // Gut. 2018. Vol. 67. P. 1380–1399. DOI: 10.1136/ gutjnl-2017-315909.

6. Azer S.A., Akhondi H. Gastritis // Treasure Island (FL): StatPearls Publishing. 2022. PMID: 31334970. https://pubmed.ncbi.nlm.nih.gov/31334970/.

7. Babai S., Auclert L., Le-Louët H. Safety data and withdrawal of hepatotoxic drugs // Therapie. 2021. Vol. 76. P. 715.

8. Bielsa-Fernández M.V., Tamayo-de la Cuesta J.L., Lizárraga-López J. et al. The Mexican consensus on the diagnosis, treatment, and prevention of NSAID-induced gastropathy and enteropathy // Revista De Gastroenterologia De Mexico. 2019. Vol. 85. Issue 2. P. 190–206.

9. Björck M., Koelemay М., Acosta S. et al. Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS) // Eur. J. Vasc. Endovasc. Surg. 2017. N. 53. P. 460e510. DOI: 10.1016/j.ejvs.2017.01.010.

10. Blaho M., Dítě P., Kunovský L., Kianička B. Autoimmune pancreatitis — An ongoing challenge // Adv. Med. Sci. 2020. Vol. 65. P. 403–408. DOI: 10.1016/j.advms.2020.07.002.

11. Bogomolov P.O. et al. Clinical study report, groups A–D. A multicentre, open-label, randomized, comparative, parallel-arm phase II study to assess efficacy and safety of Myrcludex B in combination with peginterferon alfa-2a versus peginterferon alfa-2a alone in patients with chronic viral hepatitis B with delta-agent. Final version 1.0, 11.09.2019. 141 p.

12. Bohan T.P., Helton E., McDonald I. et al. Effect of L-carnitine treatment for valproate-induced hepatotoxicity // Neurology. 2001. Vol. 56. P. 1405.

13. Brandt L.J., Feuerstadt P., Longstreth G.F., Boley S.J. ACG Clinical Guideline: Epidemiology, Risk Factors, Patterns of Presentation, Diagnosis and Management of Colon Ischemia (CI) // Am. J. Gastroenterol. 2015. Vol. 110. P. 18–44. DOI: 10.1038/ajg.2014.395.

14. Buxton I.O. Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism, and Elimination // Brunton L.L., Hilal-Dandan R., Knollmann B.C. Goodman and Gilman's: The Pharmacological Basis of Therapeutics. McGraw Hill, 2017.

15. Chalasani N., Younossi Z., Lavine J.E. et al. The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases // Hepatol. 2018. Vol. 67. N. 1. P. 328–357. DOI: 10.1002/hep.29367.

16. Chang C.Y., Schiano T.D. Review article: drug hepatotoxicity // Aliment. Pharmacol. Ther. 2007. Vol. 25. P. 1135.

17. Chen M., Zhang J., Wang Y. et al. The liver toxicity knowledge base: a systems approach to a complex end point // Clin. Pharmacol. Ther. 2013. Vol. 93. P. 409.

18. Chow C.M., Leung A.K.C., Hon K.L. Acute gastroenteritis: from guidelines to real life // Clin. Exp. Gastroenter. 2010. N. 3. Р. 97–112.

19. Davis B.R., Lee-Kong S.A., Migaly J. et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Hemorrhoids // Dis. Colon. Rectum. 2018. Vol. 61. P. 284–292. DOI: 10.1097/DCR.0000000000001030.

20. Dignan F.L., Wynn R.F., Hadzic N. et al. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation // Br. J. Haematol. 2013. Vol. 163. P. 444–457. DOI: 10.1111/bjh.12558.

21. Diverticular disease: diagnosis and management NICE guideline 2019 // www.nice.org.uk/guidance/ng147.

22. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infectionq European Association for the Study of the Liver // J. Hepatol. 2017. Vol. 67. P. j 370–398. https://easl.eu/wp-content/uploads/2018/10/HepB-English-report.pdf.

23. EASL 2021. Advances in new drugs to for curing Hepatitis B and Hepatitis D announced at ILC 2021. https://easl.eu/press-release/advances-in-new-drugs-to-for-curing-hepatitis-b-and-hepatitis-d-announced-at-ilc-2021/.

24. EASL Clinical Practice Guidelines for HFE hemochromatosis // J. Hepatol. 2010. Vol. 53. P. j 3–22.

25. EASL Clinical Practice Guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis // J. Hepatol. 2010. Vol. 53. P. j 397–417.

26. EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones // J. Hepatol. 2016. Vol. 65. P. j 146–181.

27. EASL Clinical Practice Guidelines: Drug-induced liver injury // J. Hepatol. 2019. Vol. 70. P. j 1222–1261.

28. EASL Clinical Practice Guidelines: Drug-induced liver injury // J. Hepatol. 2019. Vol. 70. Issue 6. P. 1222–1261. https://www.journal-of-hepatology.eu/article/S0168-8278(19)30129-1/fulltext. DOI: 10.1016/j.jhep.2019.02.014.

29. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease // J. Hepatol. 2018. Vol. 53. P j 397–417.

30. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases // J. Hepatol. 2009. Vol. 51. P. 237–267. DOI: 10.1016/j.jhep.2009.04.009.

31. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection // J. Hepatol. 2013. J Hepatol. 2014 Feb. Vol. 60. N. 2. P. 392-420. DOI: 10.1016/j.jhep.2013.11.003.

32. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis // J. Hepatol. 2017. Vol. 67. P. j 145–172.

33. EASL Recommendations on treatment of hepatitis C: Final update of the series // J. Hepatol. 2020. Vol. 73. N. 5. P. 1170–1218. https://www.journal-of-hepatology.eu/article/S0168-8278(20)30548-1/fulltext. DOI: 10.1016/j.jhep.2020.08.018.

34. Evidence-based clinical practice guidelines for peptic ulcer disease 2020 // J. Gastroenterol. 2021. Vol. 56. P. 303–322. DOI: 10.1007/s00535-021-01769-0 FDA. https://www.fda.gov/science-research/liver-toxicity-knowledge-base-ltkb/drug-induced-liver-injury-rank-dilirank-dataset.

35. Fashner J., Gitu A.C. Diagnosis and Treatment of Peptic Ulcer Disease and H. pylori Infection // Am. Family Physician. 2015. Vol. 91. N. 4. P. 236–242.

36. Fitzsimons E.J., Cullis J.O., Thomas D.W. et al. Diagnosis and therapy of genetic haemochromatosis (review and 2017 update) // Br. J. Haematol. 2018. Vol. 181. P. 293–303.

37. Garcia-Cortes M., Robles-Diaz M., Stephens C. et al. Drug induced injury: an update // Arch. Toxicol. 2020. Vol. 94. P. 3381.

38. Gardner T.B., Adler D.G., Forsmark C.E. et al. ACG Clinical Guideline: Chronic Pancreatitis // Am. J. Gastroenterol. 2020. Vol. 115. P. 322–339. DOI:10.14309/ajg.0000000000000535.

39. Gonsalve N. Eosinophilic Gastrointestinal Disorders Clinical // Rev. Allergy and Immunol. 2019. DOI: 10.1007/s12016-019-08732-1.

40. Goyal A., Murray J. The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology // PLoS ONE. 2014. N. 9. P. e110143.

41. Hirano I., Chan E.S., Rank M.A. et al. Clinical Guidelines for the Management of Eosinophilic Esophagitis // Gastroenterol. 2020. Vol. 158. P. 1776–1786. DOI: 10.1053/j.gastro.2020.02.038.

42. Hirschfield G.M., Dyson J.K., Chapman M.H. et al. The British Society of Gastroenterology/UK- PBC primary biliary cholangitis treatment and management guidelines // Gut. 2018. Vol. 67. P. 1568–1594. DOI: 10.1136/gutjnl-2017-315259.

43. Hnepa Y.Y., Chopey I.V., Chubirko K.I., Bratasyuk A.M. Short- and long-term effects of nsaids on the gastrointestinal mucosa: complex analysis of benefits and complications prevention // Wiadomości Lekarskie. 2021. Vol. LXXIV. Issue 4. P. 1011–1018.

44. Hunt R., Lazebnik L.B., Yury C Marakhouski Y.C. et al. International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Anti-inflammatory Drugs Induced Gastropathy-ICON-G // Eur. J. Hepato-Gastroenterol. 2018. Vol. 8. N. 2. P. 148–160. DOI: 10.5005/jp-journals-10018-1281.

45. Hussaini S.H., O'Brien C.S., Despott E.J., Dalton H.R. Antibiotic therapy: a major cause of drug-induced jaundice in southwest // Engl. Eur. J. Gastroenterol. Hepatol. 2007. Vol. 19. P. 15.

46. Hye-Kyung J., Hong S.J., Lee O.Y.et al. 2019. Seoul Consensus on Esophageal Achalasia Guidelines // J. Neurogastroenterol. Motil. 2020. Vol. 26. N. 2. DOI: 10.5056/jnm20014.

47. Jakobsen J.C., Nielsen E.E., Feinberg J. et al. Direct-acting antivirals for chronic hepatitis C (Review) // Cochrane Database of Syst. Rev. 2017. Issue 6. Art. N. CD012143. DOI: 10.1002/14651858.CD012143.pub2.

48. Jawairia M., Shahzad G., Mustacchia P. Eosinophilic Gastrointestinal Diseases: Review and Update International Scholarly Research Network ISRN // Gastroenterol. 2012. Article ID 463689. P. 8. DOI: 10.5402/2012/463689.

49. Kamada T., Satoh K., Itoh T., Ito M. Evidence-based clinical practice guidelines for peptic ulcer disease // J. Gastroenterol. 2021. Vol. 56. P. 303–322. DOI: 10.1007/s00535-021-01769-0.

50. Kim Y.J., Park K.H., Park D.A. et al. Guideline for the Antibiotic Use in Acute Gastroenteritis // Infect. Chemother. 2019. Vol. 51. N. 2. P. 217–243. DOI: 10.3947/ic.2019.51.2.217.

51. Kowdley K.V., Brown K.E., Ahn J., Sundaram V. ACG Clinical Guideline: Hereditary Hemochromatosis // Am. J. Gastroenterol. 2019. Vol. 114. P. 1202–1218. DOI: 10.14309/ajg.0000000000000315.

52. Lahner E., Zagari R.M., Zullo A. et al. Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI] // Digestive and Liver Dis. 2019. Vol. 51. P. 1621–1632. DOI: 10.1016/j.dld.2019.09.016.

53. Lahner E., Zagarib R.M., Zulloc A., Di Sabatinod A. Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI] // Digestive and Liver Dis. 2019. Vol. 51. P. 1621–1632.

54. Lanza F.L., Chan F. K.L., Quigley E.M.M. et al. Guidelines for Prevention of NSAID-Related Ulcer Complications // Am. J. Gastroenterol. 2009. Vol. 104. P. 728–738. DOI: 10.1038/ajg.2009.115.

55. Larson A.M., Polson J., Fontana R.J. et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study // Hepatol. 2005. Vol. 42. P. 1364.

56. Lin L., Wong H. Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models // Pharmaceutics. 2017. Vol. 9. N. 4. DOI:10.3390/pharmaceutics9040041.

57. Livzan M.A., Gaus O.V., Mozgovoi S.I., Bordin D.S. Chronic Autoimmune Gastritis: Modern Diagnostic Principles // Diagnostics. 2021. N. 11. P. 2113. DOI: 10.3390/diagnostics11112113.

58. Livzan M.A., Gaus O.V., Mozgovoi S.I., Bordin D.S. Chronic Autoimmune Gastritis: Modern Diagnostic Principles // Diagnostics. 2021. N. 11. P. 2113. DOI: 10.3390/diagnostics11112113.